1. Home
  2. CRWS vs CUE Comparison

CRWS vs CUE Comparison

Compare CRWS & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.73

Market Cap

28.6M

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.26

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
CUE
Founded
1957
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
27.8M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CRWS
CUE
Price
$2.73
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
24.9K
804.6K
Earning Date
02-11-2026
03-16-2026
Dividend Yield
12.07%
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
$70,270,000.00
$27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
6.51
195.75
52 Week Low
$2.35
$0.23
52 Week High
$3.88
$1.05

Technical Indicators

Market Signals
Indicator
CRWS
CUE
Relative Strength Index (RSI) 40.86 38.07
Support Level $2.54 $0.23
Resistance Level $2.94 $0.35
Average True Range (ATR) 0.09 0.03
MACD -0.02 -0.00
Stochastic Oscillator 26.58 18.42

Price Performance

Historical Comparison
CRWS
CUE

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: